Key result
An elevated albumin-bilirubin (ALBI) score ≥2.27 was associated with significantly higher in-hospital mortality in patients with heart failure (OR 1.671; 95% CI 1.228-2.274; p=0.001).
Why the study?
Liver dysfunction is prevalent in patients with HF and can lead to poor prognosis, and the ALBI score is an effective and convenient scoring system for assessing liver function.
Does the albumin-bilirubin (ALBI) score predict in-hospital mortality in patients with heart failure?
Cohort (n=9,749)
Does the albumin-bilirubin (ALBI) score predict in-hospital mortality in patients with heart failure?
The ALBI score is an independent predictor of in-hospital mortality in heart failure patients and enhances the prognostic value of NT-proBNP.
ALBI may refine in-hospital HF risk stratification; hypothesis-generating and requires prospective validation before clinical adoption.
OBJECTIVES: Liver dysfunction is prevalent in patients with heart failure (HF) and can lead to poor prognosis. The albumin-bilirubin (ALBI) score is considered as an effective and convenient scoring system for assessing liver function. We analysed the correlation between ALBI and in-hospital mortality in patients with HF. DESIGN: A retrospective cohort study. SETTING AND PARTICIPANTS: A total of 9749 patients with HF (from January 2013 to December 2018) was enrolled and retrospectively analysed. MAIN OUTCOME MEASURES: The main outcome is in-hospital mortality. RESULTS: bilirubin [umol/L] * 0.66) + (albumin [g/L] * -0.085), and analysed as a continuous variable as well as according to three categories. Following adjustment for multivariate analysis, patients which occurred in-hospital death was remarkably elevated in tertile 3 group (ALBI ≥2.27) (OR 1.671, 95% CI 1.228 to 2.274, p=0.001), relative to the other two groups (tertile 1: ≤2.59; tertile 2: -2.59 to -2.27). Considering ALBI score as a continuous variable, the in-hospital mortality among patients with HF increased by 8.2% for every 0.1-point increase in ALBI score (OR 1.082; 95% CI 1.052 to 1.114; p<0.001). The ALBI score for predicting in-hospital mortality under C-statistic was 0.650 (95% CI 0.641 to 0.660, p<0.001) and the cut-off value of ALBI score was -2.32 with a specificity of 0.630 and a sensitivity of 0.632. Moreover, ALBI score can enhance the predictive potential of NT-pro-BNP (NT-pro-BNP +ALBI vs NT-pro-BNP: C-statistic: z=1.990, p=0.0467; net reclassification improvement=0.4012, p<0.001; integrated discrimination improvement=0.0082, p<0.001). CONCLUSIONS: In patients with HF, the ALBI score was an independent prognosticator of in-hospital mortality. The predictive significance of NT-proBNP +ALBI score was superior to NT-proBNP, and ALBI score can enhance the predictive potential of NT-proBNP.
No takes yet. Share an insight, caveat, or question.
Su et al. (2022) conducted a cohort in Heart failure (n=9,749). Albumin-bilirubin (ALBI) score vs. Lower ALBI score categories (tertile 1 and 2) was evaluated on In-hospital mortality (OR 1.671, 95% CI 1.228 to 2.274, p=0.001). An elevated albumin-bilirubin (ALBI) score ≥2.27 was associated with significantly higher in-hospital mortality in patients with heart failure (OR 1.671; 95% CI 1.228-2.274; p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: